Hartmut Döhner (Harmut Dӧhner, H Döhner, Hartmut Doehner)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 50

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Clinical Evaluation

Ejection Fraction

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Hartmut Döhner, Keith W Pratz, Courtney D D DiNardo, Andrew H Wei, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Christian Recher, Andre C Schuh, Sunil Babu, Xiaotong Li, Grace Ku, Zihuan Liu, Yan Sun, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A Pollyea
Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine. Blood (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia (2024)
Hartmut Döhner, Courtney D D DiNardo, Andrew H Wei, Bob Löwenberg, Frederick Appelbaum, Charles F Craddock, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert J Ossenkoppele, Christoph Röllig, Sierra Jorge, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jian-Xiang Wang, Agnieszka Świątek
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop M Kantarjian, Christian Récher, Michael T Byrne, Elzbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Arpad Illes, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey O'Connell, Yong Hao, Harold Neal Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: randomized phase 3 ASTRAL-2 trial. Blood advances (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Gabriele Greve, Geoffroy Andrieux, Pascal Schlosser, Nadja Blagitko-Dorfs, Usama-Ur Rehman, Tobias Ma, Dietmar Pfeifer, Gerhard Heil, Andreas Neubauer, Jürgen Krauter, Michael Heuser, Helmut R Salih, Konstanze Döhner, Hartmut Döhner, Björn Hackanson, Melanie Boerries, Michael Lübbert
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts. Leukemia (2023)
Pierre Fenaux, Marco Gobbi, Patricia Kropf, Jean-Pierre J Issa, Gail J Roboz, Jiri Mayer, Jürgen Krauter, Tadeusz Robak, Hagop M Kantarjian, Jan Novak, Wieslaw Wiktor Jedrzejczak, Xavier Thomas, Mario Ojeda-Uribe, Yasushi Miyazaki, Yoo Hong Min, Su-Peng Yeh, Joseph M Brandwein, Liana Todorova Gercheva-Kyuchukova, Judit Demeter, Elizabeth A Griffiths, Karen W L Yee, Konstanze Döhner, Yong Hao, Harold Neal Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study. Blood advances (2023)
Frank Stegelmann, Lino L Teichmann, Florian H Heidel, Carl C Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim Henrik Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN). Leukemia (2023)
Pascal Naef, Ramin Radpour, Carla A Jaeger, Nils Bodmer, Gabriela M Baerlocher, Hartmut Döhner, Konstanze Doehner, Carsten Riether, Adrian Franz Ochsenbein
IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Science signaling 16 (800) (2023)
Felicitas R Thol, Hartmut Döhner, Arnold Ganser
How I treat refractory and relapsed acute myeloid leukemia. Blood (2023)
Farhad Ravandi, Hartmut Döhner, Andrew H Wei, Pau Montesinos, Michael Pfeilstöcker, Cristina Papayannidis, Yinzhi Lai, Kefeng Wang, Wendy L See, Daniel Lopes de Menezes, Erica Petrlik, Thomas Prebet, Gail J Roboz
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001. British journal of haematology (2023)
Gordon Winter, Carmen Hamp-Goldstein, Gabriel Fischer, Peter Kletting, Gerhard Glatting, Christoph Solbach, Hendrik Herrmann, Elisa Sala, Michaela Feuring, Hartmut Döhner, Ambros J Beer, Donald Bunjes, Vikas Prasad
Optimization of Radiolabeling of a [ 90 Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation. Cancers 15 (14) (2023)
A L Illert, Albrecht Stenzinger, Michael Bitzer, Peter Horak, V I Gaidzik, Y Möller, J Beha, Ö Öner, F Schmitt, S Laßmann, S Ossowski, C P Schaaf, M Hallek, Tim Henrik Brümmendorf, P Albers, T Fehm, P Brossart, H Glimm, Dirk Schadendorf, A Bleckmann, Christian H Brandts, I Esposito, E Mack, C Peters, C Bokemeyer, Stefan Fröhling, T Kindler, Hana Algül, V Heinemann, Hartmut Döhner, Ralf Christian Bargou, V Ellenrieder, P Hillemanns, F Lordick, A Hochhaus, M W Beckmann, T Pukrop, M Trepel, L Sundmacher, S Wesselmann, G Nettekoven, F Kohlhuber, O Heinze, Jan Budczies, M Werner, K Nikolaou, A J Beer, G Tabatabai, W Weichert, U Keilholz, M Boerries, Oliver Kohlbacher, J Duyster, Robert Thimme, T Seufferlein, P Schirmacher, N P Malek
The German Network for Personalized Medicine to enhance patient care and translational research. Nature medicine (2023)
Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Othman Al-Sawaf, Karl-Anton Kreuzer, Anna Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Final analysis of the CLL2-GIVe trial (obinutuzumab, ibrutinib, and venetoclax) in untreated CLL with del(17p)/TP53mut. Blood (2023)
Olga K Weinberg, Daniel A Arber, Hartmut Döhner, Charles G Mullighan, Etan Orgel, Anna Porwit, Richard M Stone, Michael J Borowitz
The International Consensus Classification of Acute Leukemias of Ambiguous Lineage. Blood (2023)
Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold N Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhner
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia (2023)
Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold N Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhner
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia (2023)
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E Bueso-Ramos, Jorge E Cortes, Paola Dal Cin, Courtney D D DiNardo, Hervé Dombret, Eric J Duncavage, Benjamin L Ebert, Elihu H Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S Hobbs, Ronald Hoffman, Elias J Jabbour, Jean-Jacques Kiladjian, Richard A Larson, Michelle M Le Beau, Mignon L-C Loh, Bob Löwenberg, Elizabeth A Macintyre, Luca Malcovati, Charles G Mullighan, Charlotte M Niemeyer, Olatoyosi M Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R Savona, Charles A Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A Stock, Richard M Stone, Martin S Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro Maria Maria Vannucchi, Paresh Vyas, Andrew H Wei, Olga K Weinberg, Agnieszka Świątek, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140 (11) (2022)
Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Christian Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H Brandts, Peter Brossart, Sara Yvonne Brucker, Tim Henrik Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia M Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. Journal of cancer research and clinical oncology (2022)
Jochen Greiner, Marlies Goetz, Patrick J Schuler, Christiane Bulach, Susanne Hofmann, Hubert Schrezenmeier, Hartmut Döhner, Vanessa Schneider, Barbara-Ann Guinn
Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody. British journal of haematology 198 (5) (2022)
Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, Charles Craddock, Courtney D D DiNardo, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert Ossenkoppele, Christoph Röllig, Sierra Jorge, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jian-Xiang Wang, Agnieszka Świątek, Bob Löwenberg
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140 (12) (2022)
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie D Freeman, Yoann Pradat, Sean J Johnson, Robert Hills, Richard Dilon, Max Fine Levine, Daniel A Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard A Adams, Hartmut Döhner, Peter J Campbell, Alan K Burnett, Michael Dennis, Nigel H Russell, Sean M Devlin, Brian James Patrick Huntly, Elli Papaemmanuil
Unified classification and risk-stratification in Acute Myeloid Leukemia. Nature communications 13 (1) (2022)
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, Courtney D D DiNardo, Lucy A Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro Maria Maria Vannucchi, Keyur Pravinchandra Patel, Daniel A Arber, Maria E Arcila, Rafael Bejar, Nancy Berliner, Michael J Borowitz, Susan Branford, Anna L Brown, Catherine A Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia-Manero, Torsten Haferlach, Eva Hellström-Lindberg, Annette S Kim, Jeffery M Klco, Rami S Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David Morrall Ross, Michael R Savona, Akiko Shimamura, Radek C Skoda, Francisco Solé, Richard M Stone, Ayalew Tefferi, Matthew J Walter, David Wu, Benjamin L Ebert, Mario Cazzola
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140 (21) (2022)
Hartmut Döhner, Andrew H Wei, Gail J Roboz, Pau Montesinos, Felicitas R Thol, Farhad Ravandi, Hervé Dombret, Kimmo Porkka, Irwindeep Sandhu, Barry Skikne, Wendy L See, Manuel Ugidos, Alberto Risueño, Esther T Chan, Anjan Thakurta, C L Beach, Daniel Lopes de Menezes
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine. Blood 140 (15) (2022)
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut R Salih, Michael Lübbert, Michael W M Kühn, Thomas Schroeder, Hans Salwender, Katharina S Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard A Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications. Blood advances 6 (18) (2022)
Amer M Zeidan, Pierre Fenaux, Marco Gobbi, Jiří Mayer, Gail J Roboz, Jürgen Krauter, Tadeusz Robak, Hagop M Kantarjian, Jan Novák, Wieslaw Wiktor Jedrzejczak, Xavier Thomas, Mario Ojeda-Uribe, Yasushi Miyazaki, Yoo Hong Min, Su-Peng Yeh, Joseph M Brandwein, Liana Gercheva, Judit Demeter, Elizabeth A Griffiths, Karen W L Yee, Jean-Pierre J Issa, Jan Philipp Bewersdorf, Harold Keer, Yong Hao, Mohammad Azab, Hartmut Döhner
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy. Blood 140 (3) (2022)
Stéphane de Botton, Pau Montesinos, Andre Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H Wei, Hans Beier Ommen, Sergey Semochkin, Hee-Je Kim, Richard A Larson, Jamie Koprivnikar, Olga Frankfurt, Felicitas R Thol, Jörg Chromik, Jenny L Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María-Belén Vidriales, Vadim A Doronin, Hartmut Döhner, Amir T Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martín-Regueira, Courtney D D DiNardo
Enasidenib vs conventional care in mutant-IDH2 relapsed/refractory acute myeloidleukemia: a randomized, phase 3 trial. Blood (2022)
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Christian Recher, Andre C Schuh, Michael J Thirman, Jacqueline S Garcia, Courtney D D DiNardo, Vladimir Vorobyev, Nicola Stefano Fracchiolla, Su-Peng Yeh, Jun Ho Jang, Muhit Özcan, Kazuhito Yamamoto, Arpad Illes, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)
Hartmut Döhner, Andrew H Wei, Bob Löwenberg
Towards precision medicine for AML. Nature reviews. Clinical oncology 18 (9) (2021)
Jürgen Krauter, Walter Fiedler, Richard F Schlenk, Peter Paschka, Felicitas Thol, Michael Lübbert, Mohammed Wattad, Mareike Verbeek, Christian Könecke, Barbara Neuhaus, Armin Papkalla, Maxim Kebenko, Melanie Janning, Konstanze Döhner, Verena I Gaidzik, Heiko Becker, Christine Greil, Peter Reimer, Katharina S Götze, Hartmut Döhner, Arnold Ganser, Michael Heuser
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial). British journal of haematology 183 (2) (2019)
Faisal Basheer, George Giotopoulos, Eshwar Meduri, Haiyang Yun, Milena Mazan, Daniel Sasca, Paolo Gallipoli, Ludovica Marando, Malgorzata Gozdecka, Ryan J Asby, Olivia Sheppard, Monika Dudek, Lars Bullinger, Hartmut Döhner, Richard Dillon, Sylvie Freeman, Oliver Ottmann, Alan Burnett, Nigel Russell, Elli Papaemmanuil, Robert Hills, Peter Campbell, George S Vassiliou, Brian James Patrick Huntly
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. The Journal of experimental medicine 216 (4) (2019)
Hartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver Gerhard Ottmann
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. British journal of haematology 185 (3) (2018)
Oliver Gerhard Ottmann, Carsten Müller-Tidow, Alwin Krämer, Richard F Schlenk, Michael Lübbert, Gesine Bug, Utz Krug, Tilmann Bochtler, Florian Voss, Tillmann Taube, Dan Liu, Pilar Garin-Chesa, Hartmut Döhner
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British journal of haematology 184 (6) (2018)